Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy

被引:164
作者
Cheok, MH
Evans, WE
机构
[1] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
[2] Univ Tennessee, Memphis, TN 38105 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nrc1800
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The use of combination chemotherapy to cure acute lymphoblastic leukaemia (ALL) in children emerged in the 1980s as a paradigm for curing any disseminated cancer, and many of the therapeutic principles were subsequently applied to the treatment of other disseminated human cancers. Similarly, elucidation of the pharmacogenomics of ALL and its translation into new chemotherapeutic approaches might serve as a model for optimizing the treatment of other human cancers. Germline polymorphisms and gene-expression patterns in ALL cells have been linked to the toxicity and efficacy of chemotherapy for ALL and are beginning to emerge as useful clinical diagnostics.
引用
收藏
页码:117 / 129
页数:13
相关论文
共 118 条
[31]   Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring [J].
Golub, TR ;
Slonim, DK ;
Tamayo, P ;
Huard, C ;
Gaasenbeek, M ;
Mesirov, JP ;
Coller, H ;
Loh, ML ;
Downing, JR ;
Caligiuri, MA ;
Bloomfield, CD ;
Lander, ES .
SCIENCE, 1999, 286 (5439) :531-537
[32]   Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1 [J].
Haase, D ;
Binder, C ;
Bünger, E ;
Fonatsch, C ;
Streubel, B ;
Schnittger, S ;
Griesinger, F ;
Westphal, G ;
Schoch, C ;
Knopp, A ;
Berkovicz, D ;
Krieger, O ;
Wörmann, B ;
Hilgers, R ;
Hallier, E ;
Schulz, T .
LEUKEMIA RESEARCH, 2002, 26 (03) :249-254
[33]   Glutathione transferases [J].
Hayes, JD ;
Flanagan, JU ;
Jowsey, IR .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :51-88
[34]   Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor ST1571 and gene-expression profiles: a gene-expression study [J].
Hofmann, WK ;
de Vos, S ;
Elashoff, D ;
Gschaidmeier, H ;
Hoelzer, D ;
Koeffler, HP ;
Ottmann, OG .
LANCET, 2002, 359 (9305) :481-486
[35]   Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment [J].
Holleman, A ;
Cheok, MH ;
den Boer, ML ;
Yang, WJ ;
Veerman, AJP ;
Kazemier, KM ;
Pei, DQ ;
Cheng, C ;
Pui, CH ;
Relling, MV ;
Janka-Schaub, GE ;
Pieters, R ;
Evans, WE .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) :533-542
[36]   Polymorphism of the thiopurine S-methyltransferase gene in African-Americans [J].
Hon, YY ;
Fessing, MY ;
Pui, CH ;
Relling, MV ;
Krynetski, EY ;
Evans, WE .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :371-376
[37]   Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan [J].
Innocenti, F ;
Undevia, SD ;
Iyer, L ;
Chen, PX ;
Das, S ;
Kocherginsky, M ;
Karrison, T ;
Janisch, L ;
Ramírez, J ;
Rudin, CM ;
Vokes, EE ;
Ratain, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1382-1388
[38]   Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis [J].
Irving, JAE ;
Bloodworth, L ;
Bown, NP ;
Case, MC ;
Hogarth, LA ;
Hall, AG .
CANCER RESEARCH, 2005, 65 (08) :3053-3058
[39]   A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance [J].
Jansen, G ;
Mauritz, R ;
Drori, S ;
Sprecher, H ;
Kathmann, I ;
Bunni, M ;
Priest, DG ;
Noordhuis, P ;
Schornagel, JH ;
Pinedo, HM ;
Peters, GJ ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30189-30198
[40]   Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics [J].
Kager, L ;
Cheok, ML ;
Yang, WJ ;
Zaza, GL ;
Cheng, Q ;
Panetta, JC ;
Pui, CH ;
Downing, JR ;
Relling, MV ;
Evans, WE .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) :110-117